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The family of GCaMPs are engineered proteins that contain Ca2+ binding motifs within a
circularly permutated variant of the Aequorea Victoria green fluorescent protein (cp-GFP).
The rapidly advancing field of utilizing GCaMP reporter constructs represents a major
step forward in our ability to monitor intracellular Ca2+ dynamics. With the use of these
genetically encoded Ca2+ sensors, investigators have studied activation of endogenous Gq
types of G protein-coupled receptors (GPCRs) and subsequent rises in intracellular calcium.
Escalations in intracellular Ca2+ from GPCR activation can be faithfully monitored in space
and time as an increase in fluorescent emission from these proteins. Further, transgenic
mice are now commercially available that express GCaMPs in a Cre recombinase
dependent fashion. These GCaMP reporter mice can be bred to distinct Cre recombinase
driver mice to direct expression of this sensor in unique populations of cells. Concerning
the central nervous system (CNS), sources of calcium influx, including those arising
from Gq activation can be observed in targeted cell types like neurons or astrocytes.
This powerful genetic method allows simultaneous monitoring of the activity of dozens
of cells upon activation of endogenous Gq-coupled GPCRs. Therefore, in combination
with pharmacological tools, this strategy of monitoring GPCR activation is amenable to
analysis of orthosteric and allosteric ligands of Gq-coupled receptors in their endogenous
environments.
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INTRODUCTION
Guanosine nucleotide-binding proteins (G proteins) are intracel-
lular proteins involved in transmitting signals from outside a cell
to the inside of the cell (Oldham and Hamm, 2008). Since their
initial detection in the 1960’s by Nobel laureates Martin Rodbell
and Alfred Gilman, heterotrimeric forms of G proteins (Gα, Gβ
and Gγ) have received much consideration in the general fields
of pharmacology, biochemistry and neuroscience. This is justified
as their interacting, coupled receptors have been an established
source of clinically active therapeutics. Several G proteins contain
lipid modifications on one or more of their subunits to enable
targeting to the plasma membrane while facilitating protein inter-
actions. The precise arrangement and targeting of subunits in
heterotrimeric G proteins affects not only which receptor with
which it can interact, but also the downstream effector target.
This general scheme of extracellular signal transduction has been
selected for across evolution and has been repeated in nature
abundantly. Built-in flexibilities originating from unique recep-
tors, G-proteins and effectors provide the means to distribute
distinct physiological response pathways to external stimuli rang-
ing from photons to complex protein hormones (Katritch et al.,
2013).
There are ∼16 genes found in human that encode different
forms of Gα which belong to a larger group of enzymes called
GTPases. The Gα subunit of heterotrimeic G proteins is highly
controlled by factors that influence its ability to bind to guanosine
triphosphate (GTP). The GTPase activity of Gα proteins hydrolyze
GTP to guanosine diphosphate (GDP). When bound by GTP, Gα
is considered in an active state and when bound by GDP, Gα is
in a less active state (Limbird, 2004). The time course of the G
protein signal is controlled by the duration of the GTP-bound
alpha subunit, which can be regulated by RGS (regulators of G
protein signaling) proteins, GEFs (guanine nucleotide exchange
factors) or by covalent modifications. Gα subunits mediate the
signal transduction pathway that initiates from an agonist occu-
pied receptor to numerous intracellular effector proteins. For
example, Gαsubunits in the Gα family stimulate the production
of 3′-5′-cyclic adenosine monophosphate (cAMP) by activation
of adenylyl cyclase. Another prominent branch of this family of
biological signaling tools includes Gαq.
Gαq and a closely related gene Gα11, are broadly expressed
and maintain homeostatic processes in digestive, urinary, car-
diovascular and central nervous systems (CNS). It is critical to
appreciate that activated Gq/11 results in several parallel signaling
pathways that include mitogen activated protein kinase (MAPK)
and the phosphatidylinositol-3-kinase (PI3K)/AKT pathways.
However, the pathway in which GTP bound Gq/11 (as well as
some combinations of Gβγ) can stimulate the activity of the
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FIGURE 1 | Overview of Gq/11-coupled GPCR signal detection by GCaMP
sensors. Schematic diagram illustrating the canonical signaling pathway of
Gq/11-coupled GPCRs. Heptahelical dimeric receptors bound by agonist can
activate the Gq/11 pathway to increase intracellular Ca2+. The signaling
intermediaries facilitating Ca2+ elevations include generation of IP3 and DAG
from PLC activation, gating of IP3 receptors embedded in the ER and release
of intracellular Ca2+ stores. Free Ca2+ can then bind to GCaMP sensors in
the cytoplasm, resulting in enhanced fluorescence. Abbreviations: N:
amino-terminus C: carboxy-terminus; PLC: phospholipase C; DAG:
diacylglycerol, IP3: inositol trisphosphate; 1F: change in fluorescence.
effector protein phospholipase Cβ (PLCβ) is the most studied
(Wettschureck and Offermanns, 2005). PLCβ hydrolyzes phos-
phatidylinositol 4,5-bisphosphate (PIP2) to diacyl glycerol (DAG)
and inositol trisphosphate (IP3). An increase in intracellular IP3
rapidly gates ionotropic IP3 receptors embedded in membranes
of endoplasmic reticulum (ER). IP3 receptor activation results in
the flux of calcium ions (Ca2+) from highly concentrated internal
ER stores to low concentration intracellular cytoplasmic regions
via channel gating (Figure 1). It is this branch of the canonical
Gαq/11 signal transduction pathway that will be the focal point of
this review.
A vast amount of research has recognized an enormous array
of extracellular and intracellular stimuli that dictate changes in
the intracellular second messenger Ca2+. The concentration over
time profile of this divalent cation has variable functions in
nearly every cell type throughout the animal kingdom (Berridge,
2006). Cells devote considerable energy in adjusting and main-
taining a steep gradient between intracellular (<1 uM) and
extracellular (>1 mM) Ca2+ concentrations. Intracellular cal-
cium signals regulate processes that operate over time ranges
varying from milliseconds to days. One general class of calcium
mobilizing external stimuli includes agonists acting at Gq/11-
coupled receptors. Examples of some G protein-coupled recep-
tors (GPCRs) that preferentially interact with Gq/11 include the
group I metabotropic glutamate; M1, M3, and M5 muscarinic
acetylcholine; 5-HT2 serotonergic, α1 adrenergic, vasopressin,
angiotensin II and histamine H1 receptors among several others.
A great deal of our knowledge base of these receptor subtypes
has its origins in the cloning era of these genes. The coding regions
of many Gq/11-coupled GPCRs were inserted into recombinant,
mammalian directed expression vectors and subsequently driven
to be transcribed by strong promotors into a variety of host
cells. Some of these expression studies have greatly contributed
to our atomic level structural understanding and knowledge of
these critical receptor subtypes. Expression strategies have served
many other useful purposes including pharmacological profiling,
detailed determination of signal transduction pathways as well as
site-directed mutagenesis studies of critical amino acids involved
in structure, function and ligand binding. However, one caveat
with this general paradigm is the issue of over-expression of the
receptor.
Does placing too many of the same receptor type bias a
signal transduction pathway through mass action relationships?
Can over-expression lead to too many spare receptors and lead
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to aberrant constitutive activity? Questions like these have been
addressed and will need to be monitored heading into the future
utilizing this set of critical tools and methodologies. Nevertheless,
methods examining Gαq/11-coupled GPCRs in their endogenous
states, which more closely reflect the natural environment, are
becoming sharper and increasingly more available. The focus of
this review article will address combining methods and paradigms
from the fields of calcium imaging, mouse genetics and pharma-
cology to uncover endogenous Gαq/11-coupled GPCRs and their
responses to acute or sustained stimulation at the molecular and
cellular levels.
GENETIC IDENTIFICATION OF CELLS WITH ENDOGENOUS
GPCRs
Investigations into the role of endogenous Gq/11-coupled GPCRs
in selective cells has become more prevalent using the power of
transgenic animals. Temporally and spatially regulated genes can
be monitored with fluorescent microscopy in mice by utilizing
a DNA recombination system based on Cre recombinase. Cre
based systems using P1 bacteriophage Cre recombinase which
catalyze the excision of DNA located between flanking loxP sites,
has been widely used since its first application in eukaryotic cells
and transgenic mice (Sauer, 1987; Novak et al., 2000). Because
recombination does not occur between the loxP sites until Cre is
introduced, the modifications are termed conditional alterations.
It is a conditional situation based on where and when the Cre
recombinase gene is expressed. This powerful strategy permits
the design of mouse lines with silent genetic manipulations (i.e.,
the flanking loxP sites) that can be un-silenced by Cre mediated
recombination. In the beginning years of the twenty-first century,
it became common in many laboratories to breed unique Cre
recombinase “driver” mice to a mate carrying a silent flanking
loxP mutation. Offspring could be produced that eliminated a
coding region of a gene to generate tissue selective knock-out of
a gene of interest. More recently, a variant of this general strategy
has become popular by placing stop codons in between the loxP
sites so as to “report” a gene, rather than eliminate it (Madisen
et al., 2010). The usefulness of this technique is enhanced with
distinct, commercially available reporter lines of mice (Figure 2).
Illustrated in Figure 2 is an example of this latter method that
permits fluorescent identification of target cells or tissues that may
express a Gq/11-coupled GPCR like neurons in layer five of cortex
or striatal projection neurons.
A more straightforward genetic alternative to this approach
includes the use of mice carrying bacterial artificial chromo-
some (BAC) transgenes. It is now routine to accurately drive
the expression of genetically programmed fluorescent reporters
(e.g., eGFP or tdTomato) or Cre recombinase in specific cellu-
lar populations with these large (150–350 kbp) transgenes. The
GENSAT (Gene Expression Nervous System Atlas) project has
used this technology to generate mouse lines with targeted cellular
expression of eGFP or Cre recombinase (Gerfen et al., 2013).
One advantage that the BAC insertion technology has over earlier
transgenic methods is that the longer expanse of DNA encom-
passes much more non-coding regions containing information to
direct the accurate expression of the reporter gene in time and
space.
One critical assumption in using these methods is that the
transgene insertion does not affect the normal physiology of an
animal. However, the largely random chromosomal integration
site of the BAC construct could have aberrant side effects on
standard gene expression. Further, the large size of the inser-
tion could contain unknown regulatory elements of other genes,
again resulting in disruption of native genes. It is generally
assumed that these are low probability events. However, in one
important example in the recent literature, Kramer et al. (2011)
described that Swiss Webster (SW) mice, homozygous for the
drd2-eGFP BAC transgene had an altered phenotype (Kramer
et al., 2011). However, subsequent manuscripts described the
use of alternative background strains and/or reducing the copy
number of BAC insertions to help control for possible affects
that could lead to misinterpretations of data (Chan et al., 2012;
Nelson et al., 2012). Together, all of these studies imply that
BAC transgenic mice are extremely valuable tools that can be
utilized to advance our understanding of endogenous GPCRs
in defined cells. However, the data that results from these
animals should be interpreted with the awareness of possi-
ble genetic misregulating elements contained in the BAC con-
struct themselves or due to insertion site disruption of native
genes.
DETECTION OF CALCIUM IONS WITH DYES OR “GCaMP”
VARIANTS
As stated above, changes in intracellular Ca2+ ([Ca2+]i) can
represent a fundamental change of state in many cell types.
Biological processes ranging from cardiac muscle contraction,
insulin secretion, cell adhesion, proliferation or cell death repre-
sent cellular and molecular reactions dependent upon [Ca2+]i.
Notably, these signals vary with a time course of milliseconds
in the case of muscle contraction, to minutes in the case of
sustained insulin secretion, to hours or days in some cases of
programmed cell death. Therefore, it is critical that the period of
time in which [Ca2+]i changes occur, can be reliably monitored
in an endogenous environment. By measuring the kinetics of
calcium transients, important information can be inferred such as
properties of ligand kinetics, receptor reserve and amplification of
signaling (Charlton and Vauquelin, 2010).
The rich history of [Ca2+]i detection which dates back to
the 1960’s has recently been well reviewed (Grienberger and
Konnerth, 2012). Briefly, bioluminescent calcium binding pro-
teins like aequorin, or synthetic compounds like arsenazo III that
changed absorbance spectrum with increasing calcium gave way
to covalently modified hybrids of calcium chelating agents like
EGTA or BAPTA (Shimomura et al., 1962; Brown et al., 1975;
Tsien, 1980). This latter group of calcium indicator dyes, includ-
ing the popular Fura-2, contains a fluorescent chromophore
that can be monitored with light detection hardware. Fura-2
can be interchangeably excited with ultraviolet light at 340 nm
or 380 nm in wavelength, and the ratio of the emitted light
intensity at those two variable excitation wavelengths is directly
correlated to the amount of intracellular calcium (Grynkiewicz
et al., 1985).
Over the course of the past few decades, improvements in
several variants of these fluorescent calcium indicators have been
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FIGURE 2 | Genetic identification of cells using cre-lox driver: reporter
methods. (A) Mating a gene promotor containing “driver” mouse directed to
express cre in a selective fashion to a cre-dependent “reporter” mouse yields
offspring which may inherit the driver-reporter combination (red offspring) of
genes. Those offspring which do not inherit the combination will not express
the identification marker (non-fluorescent offspring). (B) A currently used
strategy is to cross a cre driver mouse to a mouse expressing a cre-sensitive
element at a ubiquitously expressed locus like rosa26. At this locus is a Stop
codon (Stop sign with TGA) flanked by loxP sites (indicated by arrows)
designed to be excised by cre recombinase activity allowing expression of
genetically encoded fluorescent reporters (red star symbol) in the target cell
population. (C) Illustrates a confocal image of a coronal mouse brain section
from an animal inheriting the drd1; cre and rosa26; tdTomato genes described
above, permitting fluorescent detection of dopamine D1 cells in cortex (left)
and striatum (right). (D) Live confocal image of an acute striatal brain slice
showing drd2: tdTomato neurons (red, left) and the same section bulk loaded
with the calcium sensitive dye Flou-8 (green, center ), allowing genetic
identification of striatal neurons while imaging calcium (superimposed
images, right). See Partridge et al. (2014) for methods. Scale bars in (C) and
(D): 100 µm.
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developed that exhibit an increase in fluorescence upon binding
Ca2+. Cells can readily absorb membrane permeant acetyloxy-
methyl (AM) ester forms of these compounds by adding the
dissolved indicator to various types of cell preparations. Endoge-
nous, ubiquitous esterases cleave ester bonds and “trap” the now
membrane impermeant Ca2+ sensitive dye intracellularly. The
Ca2+ dependent amount of light emitted from these cells is
generally measured using fluorescence microscopy, fluorescence
microplate assays, or flow cytometry in combination with photon
detection. The pharmacological and biophysical properties of
these organic dyes have been reviewed (Paredes et al., 2008). One
disadvantage of using these synthetic dyes is that they label tissue
indiscriminately. For example, if you wish to study astrocytes in
the CNS, application of the dye to the tissue will also label neigh-
boring neurons. Further, many synthetic organic Ca2+ probes
distribute into the cytosol, mitochondria, and other organelles
making the measurements of “intracellular” Ca2+ more difficult
to interpret.
During the same time period as synthetic dyes were improving,
attempts to develop a genetically encoded [Ca2+]i sensor were
being performed. One such attempt has its origins in the use of
complementary DNA from the Aequorea victoria green fluores-
cent protein (GFP) gene (Chalfie et al., 1994). GFP is a ∼27 kD
protein that emits photons that fall within the visible spectrum
when expressed in prokaryotic or eukaryotic cells upon proper
excitation. GFP expression has become routine and widely used
to examine an extensive range of biological questions ranging
from gene expression to protein localization in living organisms.
Over the past 20 years, GFP has been a major foundation for
“directed evolution” into hundreds if not thousands of variations
of the original wtGFP, many of which are currently being used as
tools in fluorescent microscopy (Datta and Patterson, 2012). One
genetic variant that developed about 7 years after GFP’s initial
cloning was designed by Nakai et al. (2001). This research group
genetically engineered a chimeric protein termed G“CaM”P as
it was created from a fusion of circularly permutated GFP,
calmodulin (CaM), and M13, a peptide sequence from myosin
light chain kinase. Upon elevation of intracellular Ca2+, a con-
formational change occurred in GCaMP, enhancing fluorescent
emission. Not surprisingly, due to the initial success of GCaMP
as a Ca2+ sensor, it has been subsequently modified into increas-
ingly higher numerical variants. More recent genetic versions of
GCaMP are currently improving the signal-to-noise ratio of the
fluorescence indicator, show improved kinetic responses, have
variable Ca2+ binding affinities and other biophysical attributes
that provide great flexibility in detection capacity (Akerboom
et al., 2012; Sun et al., 2013). Additionally, “red shifted” genetically
encoded calcium sensors have been generated that increase the
spectral flexibility for imaging [Ca2+]i (Yamada and Mikoshiba,
2012).
GENETICALLY BASED EXPRESSION OF Ca2+ SENSORS
The combination of the mouse genetic strategies described above
and the use of improved GCaMPs to monitor [Ca2+]i in different
cell types has been accomplished (Fletcher et al., 2009; Chen
et al., 2012; Zariwala et al., 2012). These studies and others report
in genetically identifiable cell types, changes in [Ca2+]i with
enhanced fluorescence as a function of various stimuli. Frequently
in these studies, the increased signal in GCaMP fluorescence
derives from the underlying mechanisms of neuronal action
potentials and/or excitatory synaptic transmission. More broadly,
the literature focuses on extracellular calcium entry as the source
for increased cytosolic calcium signals. Among these mechanisms
include the opening of voltage-gated calcium channels, NMDA-
type glutamate receptors and calcium permeable AMPA-type glu-
tamate receptors. The biophysical and pharmacological properties
of evolving GCaMPs have improved to the detection level of single
action potentials (Tian et al., 2009; Akerboom et al., 2012; Chen
et al., 2013). This improving sensitivity has allowed investigators
to correlate to a given rise in fluorescence with an accurate esti-
mation of the number of action potentials while simultaneously
detecting fluorescence in dozens of distinct cell types (Wachowiak
et al., 2013).
However, what seems to be under-utilized by GCaMP func-
tionality in the literature to date is the versatility to monitor
increases in intracellular calcium from extracellular independent
sources. As described above, there are critical sources of calcium
which do not originate from the extracellular pool of calcium
and contribute to microdomains of Ca2+ signaling (Berridge,
2006). It is now clear that cytosolic calcium signaling originating
from extracellular or intracellular sources is capable of influencing
different domains or compartments within a cell. The importance
of these localized domains of Ca2+ is that they control distinct
spatial actions in different regions of the cell. For example, the
ER is an organelle whereby calcium is pumped against its natural
concentration gradient by proteins like the sarco-/endoplasmic
reticulum calcium ATPase (SERCA). Mitochondria are other vital
intracellular organelles that can serve as critical sources of calcium
upon proper stimulation. These two examples represent signifi-
cant reservoirs of calcium that facilitate a local rise in [Ca2+]i by a
subcellular dependent fashion. As an example of the advancing
technology integrating genetics and [Ca2+]i imaging, Li et al.
(2014) recently measured changes in Ca2+ from mitochondria
([Ca2+]m) in astrocytes using improved and compartmentalized
GCaMP probes while Bengtson et al. (2010) monitored calcium
changes within the nucleus of CA1 pyramidal neurons. While
these studies used more traditional DNA vector transfection or
viral infection methods to introduce the designed GCaMP into
selected cell types, it highlights that mitochondrial (Rizzuto et al.,
1995) or nuclear localization signal sequences can be added to the
GCaMP sensors to direct the sensor to subcellular organelles or
compartments. Other examples of clever genetic manipulations
include membrane tethering sequences fused in frame as done
with MARCKS-GCaMP2 (Mao et al., 2008) or Lck-GCaMP3
(Shigetomi et al., 2010). These latter two examples could be
important starting points to more rigorously screen Gq/11 calcium
mobilization systems.
One advantage of the genetic techniques described above is
that endogenous DNA recombination does a great deal of the
work for the investigators without any requirements for sur-
vival surgery based methods. However, more invasive techniques,
including stereotactic viral delivery or in utero electroporation
(Yamada and Mikoshiba, 2012) can be used to extend the biolog-
ical question posed.
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MONITORING ENDOGENOUS Gq/11-COUPLED
METABOTROPIC GLUTAMATE RECEPTORS USING ACUTE
BRAIN SLICE PREPARATIONS
L-glutamate is the key excitatory neurotransmitter at the majority
of synapses in the mammalian CNS. The initial detection of a
distinct “metabolic” neuromodulatory glutamate receptor capa-
ble of generating IP3 occurred almost three decades ago (Nicoletti
et al., 1986). It was also discovered during this time period that
activation of unique glutamate receptors could elevate intracel-
lular Ca2+ in a “spike like” fashion upon receptor stimulation in
the absence of extracellular Ca2+ (Murphy and Miller, 1988). The
cloning era was able to make great strides in our understanding of
the glutamate receptor family structure and function. Two main
divisions of L-glutamate binding proteins include the ionotropic
(AMPA, NMDA, and kainate) and metabotropic glutamate recep-
tors (mGluRs). Of the eight mGluRs, it is now apparent that
Group I mGluRs: mGlu1 and mGlu5 preferentially couple to
the synthesis of DAG and IP3 via Gq/11. The widespread yet
tissue specific expression of group I mGluRs suggests that these
modulatory receptors have the ability to affect various functions
in the CNS. Since their detection, mGluRs have been a focal
point of various therapeutic aims to assist in alleviating symptoms
of disease states ranging from Parkinson’s disease, diabetic neu-
ropathy, melanoma, Autism spectrum disorders and generalized
anxiety disorder (Niswender and Conn, 2010). For these reasons,
GCaMP monitoring of Gq/11-mediated rises in cytosolic calcium
can deepen our knowledge of a vital receptor class.
The Group I mGluRs are currently endowed with a rich array
of pharmacological tools to dissect out particular branches and
their role in signaling (Conn et al., 2014; Rook et al., 2015). One
frequently used tool includes the compound (S)-3,5-dihydroxy-
phenylglycine (DHPG). DHPG has been utilized as one of the
most selective Group I mGluR orthosteric agonists. Recently,
brain slice preparations of the striatum detected rises in [Ca2+]i
from genetically identified neurons following acute DHPG appli-
cation using either organic dye loading methods (Chen et al.,
2011; Plotkin et al., 2013) or GCaMP3 transgene expression
(Partridge et al., 2014). In the latter case, confocal imaging
combined with mouse genetics using dopamine D1 (drd1) or
D2 (drd2) gene driven Cre recombinase provided a scaffold to
monitor DHPG mediated changes in [Ca2+]i. The acute appli-
cation of DHPG did not affect the basal fluorescence of GCaMP3
in most of the imaged D1+ or D2+ striatal neurons (Figure 3).
However, in cells which were depolarized by either chemical
or electrical means, a robust Ca2+ signal resulted when slices
were acutely exposed to the Gq/11-coupled GPCR agonist. These
events were blocked by pretreatment with allosteric antagonists
acting at mGluR1 and mGluR5. Further, the DHPG-mediated
increase in GCaMP3 fluorescence was blocked by thapsigargin
pre-treatment, an inhibitor of SERCA, strongly supporting a
role for an intracellular source of calcium. The DHPG-mediated
activation of native mGluRs as detected by GCaMP3, was fast
and exhibited desensitization in the continued presence of this
agonist. Further, in simultaneously current-clamped and GCaMP
labeled neurons, the DHPG- mediated enhanced fluorescent sig-
nal was not associated with a change in membrane potential.
This strongly supports the feasibility of these methods to detect
active, endogenous GPCRs with GCaMP in an action-potential
independent fashion.
Together, the data from that study indicate that striatal D1+
and D2+ projection neurons in acute brain slices express Gq/11-
coupled mGluRs that can be observed with good time resolution
by calcium sensors. The ability to detect increases in GCaMP3
fluorescence was clearly enhanced by presumably “pre-filling”
the intracellular stores with calcium. However, this combination
of methods can clearly be useful to monitor dozens of distinct
neurons simultaneously while probing the native state of receptors
with pharmacological tools.
Within that same study, the flexibility of the method was
shown as GCaMP3 expression was directed to more sparse
interneurons by crossing somatostatin (sst; Taniguchi et al., 2011)
or tyrosine hydroxylase (th; Lindeberg et al., 2004) gene-driven
Cre recombination. In these striatal GABAergic interneuron sub-
types, DHPG application produced robust increases in GCaMP3
fluorescence that differed significantly in the duration of fluo-
rescent signal compared to those elicited in the drd1 or drd2
driven strains. Electrical recordings from the various GCaMP3
expressing interneuron subtypes indicated that DHPG did evoke
action potentials in the two interneuron populations in this
brain region. A recent study utilizing uncaging of IP3 came to
a similar conclusion (Clements et al., 2013). Taken together, the
data suggest a more classical type of Gq/11-mediated change in
intracellular calcium in projection type drd1 or drd2 expressing
neurons. In contrast, the actions of DHPG acting upon interneu-
ron populations could be utilizing the ability of Gq/11 to couple
to various TRP type channels (Gee et al., 2003; Ramsey et al.,
2006). TRP channels were initially found to mediate photo-
transduction in fruit flies and are non-selection cation channels.
The open probability of several types of TRP channels can be
enhanced upon activation of Gq/11-coupled GPCRs. While more
pharmacological evidence is necessary to validate this alternate
pathway in striatal interneurons, this highlights the importance of
the interpretation of the data. These studies and certainly others
represent multidisciplinary techniques with rapidly evolving tools
in which GPCRs can be assayed in natural states with relatively
high temporal precision. This can greatly contribute to a deeper
understanding of GPCR pharmacology while investigating the
enormous heterogeneity of CNS cell types.
CONCLUDING REMARKS AND FUTURE DIRECTIONS
G protein-coupled receptor signaling is a fundamental
membrane-bound mechanism to detect selective changes in
the local environment of animal cells. Because of the universal
instrumentation of GPCRs across the animal kingdom, it is
essential to understand the basic mechanisms on which they
operate in an endogenous environment. Despite tremendous
progress in our understanding of GPCR physiology and
pharmacology, wide gaps remain in bridging the use of molecules
that target these pathways to alleviate symptoms of disease
and to develop clinically useful therapeutics. While this review
has focused on one branch of the GPCR superfamily signaling
pathway, opportunities to explore other canonical pathways like
cAMP generation are being developed with luciferase based
methods (Binkowski et al., 2011; DiRaddo et al., 2014). However,
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FIGURE 3 | Directed expression of genetically encoded
calcium sensors to detect Gq/11-GPCR activation. (A) Mating a “driver”
mouse directed to express cre in a selective dopamine D2 (drd2) fashion to a
cre-dependent “reporter” GCaMP 3 mouse yields offspring which may inherit
the driver-reporter combination of genes (green offspring). The offspring
which do not inherit this combination will not express the calcium detector
(non-fluorescent offspring). (B) Illustrates a confocal image of a coronal mouse
brain section from an animal inheriting the drd2; cre and rosa26; GCaMP3
genes, permitting fluorescent detection of calcium changes in striatal
dopamine D2 cells. (C) Live confocal image of an acute striatal brain slice
showing drd1: GCaMP3 expressing neurons (green, left) with superimposed
regions of interest (ROI, red circles) allowing genetically targeted
calcium imaging. To the right are shown the time course of changes in [Ca2+]i
(1F/F) in the ROIs corresponding to cell bodies. Each trace represents a
different ROI or cell body. The top horizontal bars above the traces represent
the time duration that the drugs DHPG (10 µM, open bars), or NMDA
(20 µM, filled bars) were acutely applied. Note the ability to detect GPCR
activation following activation of the cells. Scale bars in (B) and (C): 100 µm.
fluorescent protein-based cAMP indicators have lagged behind
Ca2+ sensors and require further development with improved
dynamic range and brightness.
Another goal moving forward in the GPCR field is to develop a
“universal” detector of endogenous GPCR activation. The detec-
tion of protein–protein interactions (e.g., receptor-G-proteins,
liberation of Gβγ) would be one requirement of such a sensor.
In fact, GPCR activation has been observed with several imag-
ing probe techniques including intramolecular and intermolec-
ular Förster resonance energy transfer (FRET)-based genetically
encoded indicators (Lohse et al., 2012). However, an apparent
constraint of this technique is that the introduction of dual
fluorescent proteins (i.e., one acceptor and one donor), likely
introduces steric hindrance and obstruction of essential protein–
protein interactions necessary for energy transfer and the study
of GPCRs in their endogenous states (Partridge et al., 2006). By
combining the fields of fluorescent microscopy, mouse genetics
and pharmacology we can enhance our understanding of GPCRs
in their native state. Unanswered questions like the formation of
various GPCR heteromers, altered pharmacology of heteromic
receptors and cellular specificity can be answered with clever
combinations of the methods mentioned in this review.
Improving GCaMP fluorescent signals have been detected
using in vivo preparations (Hinckley and Pfaff, 2013; Dana et al.,
2014), even in subcortical areas like the striatum (Cui et al., 2013).
These elegant studies relied on the firing of action potentials to
infer neuronal signaling. The challenge moving forward is to uti-
lize fluorescent signals originating from the activation of GPCRs
in vivo. This appears to be a reasonable challenge moving forward
as detection of small but reliable Ca2+ increases can be detected
in very fine mouse astrocyte processes both in vitro (Shigetomi
et al., 2013) and in vivo (Otsu et al., 2015). These observations
represent examples of calcium mobilization processes dependent
upon acute GPCR activation.
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